0001011438-16-000435.txt : 20160216 0001011438-16-000435.hdr.sgml : 20160215 20160216161002 ACCESSION NUMBER: 0001011438-16-000435 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160216 DATE AS OF CHANGE: 20160216 GROUP MEMBERS: GEORGE SOROS GROUP MEMBERS: ROBERT SOROS SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-33655 FILM NUMBER: 161428185 BUSINESS ADDRESS: STREET 1: 3333 LEE PARKWAY STREET 2: SUITE 600 CITY: DALLAS STATE: TX ZIP: 75219 BUSINESS PHONE: 2149055100 MAIL ADDRESS: STREET 1: 3333 LEE PARKWAY STREET 2: SUITE 600 CITY: DALLAS STATE: TX ZIP: 75219 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SOROS FUND MANAGEMENT LLC CENTRAL INDEX KEY: 0001029160 IRS NUMBER: 133914976 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 250 WEST 55TH STREET, FLOOR 27 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 872-1054 MAIL ADDRESS: STREET 1: 250 WEST 55TH STREET, FLOOR 27 CITY: NEW YORK STATE: NY ZIP: 10019 SC 13G/A 1 form_sc13ga-abeona.htm form_sc13ga-abeona.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

ABEONA THERAPEUTICS INC. f/k/a PlasmaTech Biopharmaceuticals, Inc.)
(Name of Issuer)

Common Stock, $0.01 par value
(Title of Class of Securities)

00289Y107
(CUSIP Number)

December 31, 2015
(Date of Event which Requires Filing
of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:


[   ]
   Rule 13d-1(b)
[X]
   Rule 13d-1(c)
[   ]
   Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Continued on following pages
Page 1 of 12 Pages
Exhibit Index: Page 9

 
 
 

CUSIP NO.  00289Y107
Page 2 of 12 Pages


1.
Names of Reporting Persons

SOROS FUND MANAGEMENT LLC


2.
Check the Appropriate Box If a Member of a Group (See Instructions)
a.  
[   ]
b.  
[X]

3.
SEC Use Only

4.
Citizenship or Place of Organization

DELAWARE

 
5.
Sole Voting Power
Number of
Shares
  
1,712,122
Beneficially
Owned By
Each
6.
Shared Voting Power
0
Reporting
Person
With
7.
Sole Dispositive Power
1,712,122
 
8.
Shared Dispositive Power
   
0


9.
Aggregate Amount Beneficially Owned by Each Reporting Person

1,712,122

10.
Check Box If the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

[   ]

11.
Percent of Class Represented By Amount in Row (9)


5.19%

12.
Type of Reporting Person (See Instructions)

OO




 
 
 

CUSIP NO.  00289Y107
Page 3 of 12 Pages


1.
Names of Reporting Persons

GEORGE SOROS


2.
Check the Appropriate Box If a Member of a Group (See Instructions)
a.  
[   ]
b.  
[X]

3.
SEC Use Only

4.
Citizenship or Place of Organization

UNITED STATES

 
5.
Sole Voting Power
Number of
Shares
  
0
Beneficially
Owned By
Each
6.
Shared Voting Power
1,712,122
Reporting
Person
With
7.
Sole Dispositive Power
0
 
8.
Shared Dispositive Power
   
1,712,122

9.
Aggregate Amount Beneficially Owned by Each Reporting Person

1,712,122

10.
Check Box If the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

[   ]

11.
Percent of Class Represented By Amount in Row (9)

5.19%

12.
Type of Reporting Person (See Instructions)

IN

 
 
 

CUSIP NO.  00289Y107
Page 4 of 12 Pages


1.
Names of Reporting Persons

ROBERT SOROS


2.
Check the Appropriate Box If a Member of a Group (See Instructions)
a.  
[   ]
b.  
[X]

3.
SEC Use Only

4.
Citizenship or Place of Organization

UNITED STATES

 
5.
Sole Voting Power
Number of
Shares
  
0
Beneficially
Owned By
Each
6.
Shared Voting Power
1,712,122
Reporting
Person
With
7.
Sole Dispositive Power
0
 
8.
Shared Dispositive Power
   
1,712,122


9.
Aggregate Amount Beneficially Owned by Each Reporting Person

1,712,122
 
 
10.
Check Box If the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

[   ]

11.
Percent of Class Represented By Amount in Row (9)

5.19%

12.
Type of Reporting Person (See Instructions)

IN

 
 
 

CUSIP NO.  00289Y107
Page 5 of 12 Pages


Item 1(a).
Name of Issuer:
   
 
Abeona Therapeutics Inc. (f/k/a PlasmaTech Biopharmaceuticals, Inc.) (the "Issuer").
   
Item 1(b).
Address of the Issuer's Principal Executive Offices:
   
 
3333 Lee Parkway, Suite 600
 
Dallas, TX 75219
   
Item 2(a).
Name of Person Filing
   
 
The Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

i)  
Soros Fund Management LLC (“SFM LLC”);

ii)  
George Soros; and

iii)  
Robert Soros.

 
This statement relates to Shares (as defined herein) held for the account of Quantum Partners LP, a Cayman Islands exempted limited partnership (“Quantum Partners”).  SFM LLC serves as principal investment manager to Quantum Partners.  As such, SFM LLC has been granted investment discretion over portfolio investments, including the Shares, held for the account of Quantum Partners.  George Soros serves as Chairman of SFM LLC and Robert Soros serves as President and Deputy Chairman of SFM LLC.

Item 2(b).
Address of Principal Business Office or, if None, Residence:
   
 
The address of the principal business office of each of the Reporting Persons is 250 West 55th Street, 38th Floor, New York, NY 10019.

Item 2(c).
Citizenship:

i)  
SFM LLC is a Delaware limited liability company;

ii)  
George Soros is a United States citizen; and

iii)  
Robert Soros is a United States citizen.

Item 2(d).
Title of Class of Securities:
 
 
Common Stock, $0.01 par value (the “Shares”).
 
Item 2(e).
CUSIP Number:
   
 
00289Y107

 
 
 

CUSIP NO.  00289Y107
Page 6 of 12 Pages


Item 3.
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
 
 
This Item 3 is not applicable.
 
Item 4.
Ownership:
   
Item 4(a).
Amount Beneficially Owned:
   
 
As of February 15, 2016, each of the Reporting Persons may be deemed to be the beneficial owner of 1,712,122 Shares.  This number includes (A) 1,462,122 Shares and (B) 250,000 Shares issuable upon the exercise of warrants (the “Warrants”) beneficially owned by the Reporting Persons.
   
Item 4(b).
Percent of Class:
   
 
As of February 15, 2016, assuming full exercise of the Warrants beneficially owned by the Reporting Persons, each of the Reporting Persons may be deemed to be the beneficial owner of approximately 5.19% of the total number of Shares outstanding.
   
Item 4(c).
Number of shares as to which such person has:
   

 
SFM LLC
 
(i)
Sole power to vote or direct the vote
1,712,122
 
(ii)
Shared power to vote or to direct the vote
0
 
(iii)
Sole power to dispose or to direct the disposition of
1,712,122
 
(iv)
Shared power to dispose or to direct the disposition of
0

 
George Soros
 
(i)
Sole power to vote or direct the vote
0
 
(ii)
Shared power to vote or to direct the vote
1,712,122
 
(iii)
Sole power to dispose or to direct the disposition of
0
 
(iv)
Shared power to dispose or to direct the disposition of
1,712,122

 
Robert Soros
 
(i)
Sole power to vote or direct the vote
0
 
(ii)
Shared power to vote or to direct the vote
1,712,122
 
(iii)
Sole power to dispose or to direct the disposition of
0
 
(iv)
Shared power to dispose or to direct the disposition of
1,712,122


 
 
 

CUSIP NO.  00289Y107
Page7 of 12 Pages




Item 5.
Ownership of Five Percent or Less of a Class:
   
 
This Item 5 is not applicable.
   
Item 6.
Ownership of More than Five Percent on Behalf of Another Person:
   
 
The partners of Quantum Partners are entitled to receive, or have the power to direct, the receipt of dividends from or the proceeds of sales of the Shares held for the account of Quantum Partners, in accordance with their ownership interests in Quantum Partners.
   
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
   
 
This Item 7 is not applicable.
   
Item 8.
Identification and Classification of Members of the Group:
   
 
This Item 8 is not applicable.
   
Item 9.
Notice of Dissolution of Group:
   
 
This Item 9 is not applicable.
   
Item 10.
Certification:

 
By signing below each of the Reporting Persons certifies that, to the best of such person's knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.


 
 
 

CUSIP NO.  00289Y107
Page 8 of 12 Pages


SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.



Date:  February 16, 2016
SOROS FUND MANAGEMENT LLC
   
 
By:           /s/ Jodye Anzalotta
 
Jodye Anzalotta
 
Assistant General Counsel

Date:  February 16, 2016
GEORGE SOROS
   
 
By:           /s/ Jodye Anzalotta
 
Jodye Anzalotta
 
Attorney-in-Fact
   

Date:  February 16, 2016
ROBERT SOROS
   
 
By:           /s/ Jodye Anzalotta
 
Jodye Anzalotta
 
Attorney-in-Fact
   

   


 

 

 
 
 

CUSIP NO.  00289Y107
Page 9 of 12 Pages


EXHIBIT INDEX

   
Page No.
A.
Joint Filing Agreement, dated as of February 16, 2016, by and among Soros Fund Management LLC, George Soros, and Robert Soros
 
10
 
B.
Power of Attorney, dated as of November 24, 2015, granted by George Soros in favor of Maryann Canfield, Jodye Anzalotta , Jay Schoenfarber, Thomas O’Grady, Regan O’Neill and Robert Soros
 
11
 
C.
Power of Attorney, dated as of November 30, 2015, granted by Robert Soros in favor of Maryann Canfield, Jodye Anzalotta , Jay Schoenfarber, Thomas O’Grady, Regan O’Neill
 
12
 

 
 
 

CUSIP NO.  00289Y107
Page 10 of 12 Pages


EXHIBIT A

JOINT FILING AGREEMENT

The undersigned hereby agree that the Schedule 13G with respect to the Common Stock, $0.01 par value, of Abeona Therapeutics Inc., dated as of February 16, 2016, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.



Date:  February 16, 2016
SOROS FUND MANAGEMENT LLC
   
 
By:           /s/ Jodye Anzalotta
 
Jodye Anzalotta
 
Assistant General Counsel

Date:  February 16, 2016
GEORGE SOROS
   
 
By:           /s/ Jodye Anzalotta
 
Jodye Anzalotta
 
Attorney-in-Fact
   

Date:  February 16, 2016
ROBERT SOROS
   
 
By:           /s/ Jodye Anzalotta
 
Jodye Anzalotta
 
Attorney-in-Fact
   

   


 
 
 

CUSIP NO. 00289Y107
Page 11 of 12 Pages


EXHIBIT B

POWER OF ATTORNEY

 
KNOW ALL MEN BY THESE PRESENT, that I, GEORGE SOROS, hereby make, constitute and appoint each of MARYANN CANFIELD, JODYE ANZALOTTA, JAY SCHOENFARBER, THOMAS O’GRADY, REGAN O’NEILL and ROBERT SOROS, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Chairman of, member of or in other capacities with Soros Fund Management LLC ("SFM LLC") and each of its affiliates or entities advised by me or SFM LLC, all documents, certificates, instruments, statements, filings and agreements ("documents") to be filed with or delivered to any foreign or domestic governmental or regulatory body or required or requested by any other person or entity pursuant to any legal or regulatory requirement relating to the acquisition, ownership, management or disposition of securities, futures contracts or other investments, and any other documents relating or ancillary thereto, including without limitation all documents relating to filings with the Commodities Futures Trading Commission and National Futures Association, the United States Securities and Exchange Commission (the "SEC") pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934 (the "Act") and the rules and regulations promulgated thereunder, including all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Act and any information statements on Form 13F required to be filed with the SEC pursuant to Section 13(f) of the Act.
 
 
All past acts of these attorneys-in-fact in furtherance of the foregoing are hereby ratified and confirmed.
 
Execution of this power of attorney revokes that certain Power of Attorney dated as of the 26th day of June, 2009 with respect to the same matters addressed above.
 
This power of attorney shall be valid from the date hereof until revoked by me.
 
IN WITNESS WHEREOF, I have executed this instrument as of the 24th day of November, 2015.
 
 
GEORGE SOROS
 

/s/ Daniel Eule
Daniel Eule
Attorney-in-Fact for George Soros


 
 
 

CUSIP NO.  00289Y107
Page 12 of 12 Pages


EXHIBIT C

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENT, that I, ROBERT SOROS, hereby make, constitute and appoint each of MARYANN CANFIELD, JODYE ANZALOTTA, JAY SCHOENFARBER, THOMAS O’GRADY and REGAN O’NEILL, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Deputy Chairman of, member of or in other capacities with Soros Fund Management LLC ("SFM LLC") and each of its affiliates or entities advised by me or SFM LLC, all documents, certificates, instruments, statements, filings and agreements ("documents") to be filed with or delivered to any foreign or domestic governmental or regulatory body or required or requested by any other person or entity pursuant to any legal or regulatory requirement relating to the acquisition, ownership, management or disposition of securities, futures contracts or other investments, and any other documents relating or ancillary thereto, including without limitation all documents relating to filings with the Commodities Futures Trading Commission and National Futures Association, the United States Securities and Exchange Commission (the "SEC") pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934 (the "Act") and the rules and regulations promulgated thereunder, including all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Act and any information statements on Form 13F required to be filed with the SEC pursuant to Section 13(f) of the Act.

All past acts of these attorneys-in-fact in furtherance of the foregoing are hereby ratified and confirmed.

Execution of this power of attorney revokes that certain Power of Attorney dated as of the 3rd day of October, 2007 with respect to the same matters addressed above.

This power of attorney shall be valid from the date hereof until revoked by me.

IN WITNESS WHEREOF, I have executed this instrument as of the 30th day of November, 2015.


ROBERT SOROS

/s/ Robert Soros